Clinical Evidence


Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
Improved Removal of Free Light Chains by Hemodialysis With Medium Cut-Off Dialyzer
HDx therapy enabled by Theranova
Improved Serum Phosphorous and Small Molecule Removal With Expanded Hemodialysis and Hemodiafiltration vs. Conventional Hemodialysis: A Cross-Over Randomized Clinical Trial
HDx therapy enabled by Theranova
Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial
HDx therapy enabled by Theranova
In vitro benchmark of cytokine removal by dialyzers with various permeability profiles
HDx therapy enabled by Theranova
In Vitro Cytokine Removal: Comparison of Conventional High-Flux Dialyzers and Middle-Cut-Off Dialyzer (Theranova HDx)
HDx therapy enabled by Theranova
Innovations of renal replacement techniques at the intersection of clinical trial and real-world data.
HDx therapy enabled by Theranova
Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration
HD
Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration - Leypoldt et al.
HD
Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions? - Dolley-Hitze T et al
HDx therapy enabled by Theranova
Is Expanded Hemodialysis an Option to Online Hemodiafiltration for Small- and Middle-Sized Molecules Clearance?
HDx therapy enabled by Theranova
Large Middle Molecule and Albumin Removal: Why Should We Not Rest on Our Laurels?
HDx therapy enabled by Theranova
Large uremic toxins: an unsolved problem in end-stage kidney disease - Wolley MJ and Hutchison CA.

Vantive is a trademark of Vantive Health LLC or its affiliates.